Kobayashi Mizuki, Nomura Masayoshi, Yamada Yoji, Fujimoto Naohiro, Matsumoto Tetsuro
Department of Urology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan.
Int J Urol. 2005 Jun;12(6):581-4. doi: 10.1111/j.1442-2042.2005.01107.x.
We performed bladder-sparing surgery and continent urinary diversion in two patients with urethral cancer. The first patient was a 58-year-old man with bulbomembranous urethral cancer (squamous cell carcinoma, cT2N0M0). The second patient was a 77-year-old woman with urethral cancer invading the vaginal wall (transitional cell carcinoma with squamous cell carcinoma, cT3N0M0). After bladder-sparing urethrectomy, continent urinary diversion with appendicovesicostomy (Mitrofanoff procedure) was performed in the both patients. More than 4 years after the surgery, both patients were continent, had no trouble with catheterization, and experienced no recurrence of cancer. Bladder-sparing surgery and urinary diversion based on the Mitrofanoff procedure can be considered for appropriately selected patients with urethral cancer.
我们对两名尿道癌患者实施了保膀胱手术和可控性尿流改道术。首例患者为一名58岁男性，患有球膜部尿道癌（鳞状细胞癌，cT2N0M0）。第二例患者是一名77岁女性，尿道癌侵犯阴道壁（移行细胞癌伴鳞状细胞癌，cT3N0M0）。在保膀胱尿道切除术后，两名患者均接受了阑尾膀胱造口术（米氏手术）的可控性尿流改道术。术后4年多来，两名患者均能自主排尿，导尿无困难，且无癌症复发。对于经过适当选择的尿道癌患者，可考虑实施基于米氏手术的保膀胱手术和尿流改道术。
